@MarkHFierce: Folks, there's still time to submit your nominations for the FierceMedicalDevices Fierce 15 private device developers. Survey | Follow @MarkHFierce
@FierceMedDev: HeartWare gained expanded European approval for its HVAD implant. Trials continue in the U.S., however. Story | Follow @FierceMedDev
> Stryker's ($SYK) Trevo Retriever system to treat acute strokes generated "significantly better" post-device revascularization than a predecessor device, based on results from the company's TREVO 2 clinical trial. Release
> LabCorp ($LH) is joining forces with XDx to develop a diagnostic for lupus flares, or when the autoimmune disease acts up. Story
> Many pregnant women aren't being screened for chlamydia and gonorrhea, as per CDC recommendations, according to a new study by Quest Diagnostics ($DGX) and Rutgers University. Release
> SPR Therapeutics, a neurostimulation pain-relief device company, nailed down a $900,000 loan from the state of Ohio to help the company ramp up production of its signature product. Story
> The Michigan Medical Device Accelerator program won a $400,000 grant from the W.K. Kellogg Foundation. Plans call for using the money to fuel continue fueling more device company startups. Story
> Aerocrine in Sweden gained regulatory approval to market its Niox Mino airway inflammation monitor and test kit in Australia. Both products are meant for asthma patients. Release
Pharma News
@FiercePharma: Another German drugmaker in takeover talks: Riemser may pick shortlist by next week--Bloomberg. Story | Follow @FiercePharma
> New Teva chief slashes sales forecast by $1B. News
> EU antitrust officials probe parallel trade. Article
> Securities watchdogs reportedly probe Shanghai Pharma deals. Item
> FDA panel draws blood in Xarelto's bid for new use. Report
Biotech News
@FierceBiotech: Vitamin D boosts TB shot as cancer therapy. More | Follow @FierceBiotech
@RyanMFierce: Pfizer brings Lipitor brand to mobile app stores. Report | Follow @RyanMFierce
@JohnCFierce: So Globe's verastem coverage says best-case scenario is start trials in a year, products available in four. A three-year cancer stem cell program? Ha. | Follow @JohnCFierce
> J&J loses key FDA panel vote on Xarelto. Item
> European pharmas join forces on $285M antibiotics collaboration. News
> Sanofi chief highlights high hopes for liver cancer drug. Story
> Upstart biotech lures Vertex founder out of retirement. Report
Pharma Manufacturing News
@EricPFierce: FDA to Crescendo: We told you so. Marshals seize steroid gel from California firm that was selling unapproved drug. Report | Follow @EricPFierce
> FDA may impose more QA checks on heparin makers. Story
> Recipharm snags $114 million loan, says its shopping. Article
> Heart attack test alert from Alere. More
> FDA takes aim at Spanish drugmaker. Item
CRO News
@NesaNFierce: What should a CDMO do with 90 million Euros? Buy more CDMOs, as Recipharm announced it will do. Article | Follow @NesaNFierce
> SGS picks up testing company Vitrology for an undisclosed fee. News
> Pfizer's David Simmons joins PPD as new CEO and chairman. Story
> PRA expands European ops with new Dutch and British offices. More
> Quintiles survey shows U.S. and U.K. payers want to improve R&D with increased involvement. Item
Vaccines News
> Wishing you a happy HIV Vaccine Awareness Day. Report
> Vitamin D boosts TB shot as cancer therapy. Article
> DNA vaccine swats TB and HIV. News
> HIV vaccine carries its own adjuvant into clinical trials. Story
And Finally... Dynasil Corporation of America ($DYSL) and the Mayo Clinic will jointly develop therapeutic hypothermia core cooling technology that would protect the brain during cardiac arrest and traumatic brain injury. Release